<![CDATA[Cosper Pharma Tech Co., Ltd.]]>enThu, 08 Oct 2026 07:24:23 GMTThu, 08 Oct 2026 07:24:23 GMT<![CDATA[Synthesis route of Mitapivat]]>news-625<![CDATA[Ropivacaine Hydrochloride: A Key Local Anesthetic API for Pharmaceutical Manufacturing]]>news-624<![CDATA[Upadacitinib Intermediates Supply]]>news-623<![CDATA[Finerenone Intermediates Supply]]>news-622<![CDATA[Conivaptan Intermediates Supply]]>news-621<![CDATA[Tolvaptan Intermediates Supply]]>news-620<![CDATA[Midazolam Intermediates Supply]]>news-619<![CDATA[Darolutamide Intermediates Supply]]>news-618<![CDATA[Aromatic rings and aromatic heterocyclic systems Supply]]>news-617<![CDATA[Long-chain alkyl alcohols & ketones Supply]]>news-616<![CDATA[Enzalutamide and Intermediates Supply]]>news-615<![CDATA[Bicalutamide Intermediates Supply]]>news-614<![CDATA[Lurasidone Intermediates Supply]]>news-613<![CDATA[Pregabalin Intermediates Supply]]>news-612<![CDATA[Daraxonrasib (RMC-6236) Full Series of Intermediates Supply]]>news-611<![CDATA[MK-0616 (Enlicitide) Full Series of Intermediates Supply]]>news-610<![CDATA[Nerandomilast (BI-1015550) Full Series of Intermediates Supply]]>news-609<![CDATA[Zavegepant Full Series of Intermediates Supply]]>news-608<![CDATA[Finerenone and Full Series of Intermediates Supply]]>news-607<![CDATA[Osimertinib and Full Series of Intermediates Supply]]>news-606<![CDATA[Product Supply | Tenapanor API, its intermediates and impurities API information]]>news-605<![CDATA[Synthetic Route of Linerixibat]]>news-604<![CDATA[Arbidol Intermediates Supply by Cosperpharm]]>news-603<![CDATA[Avexitide (Exendin(9-39) amide) is the fastest-developing GLP-1 receptor antagonist worldwide; it is a linear polypeptide composed of 31 amino acids with a C-terminal amide modification.]]>news-602<![CDATA[Liraglutide: A GLP-1 receptor agonist that enhances metabolism]]>news-601<![CDATA[Daridorexant Hydrochloride COA]]>news-486<![CDATA[Iminesiru for Relebactam]]>news-485<![CDATA[Screening study of Trofinetide cocrystal‌ form]]>news-484<![CDATA[JACS: Merck has partnered with Huanquan and Conquer Biotech to publicly disclose the total synthesis process for MK-0616.]]>news-483<![CDATA[How should chelating agents be selected for targeted radionuclides?]]>news-482<![CDATA[Eutectic Technology: Opening the Door to New Drug and Modified Drug R&D]]>news-481<![CDATA[Pharmaceutical Intermediate Information]]>news-309<![CDATA[Analysis of the Synthesis Process for Eli Lilly's Key Drug: Tirzepatide]]>news-308<![CDATA[Synthetic Route Of Trofinetide]]>news-307<![CDATA[Preparation Method of Cagrilintide]]>news-306<![CDATA[The world's first topical JAK inhibitor for treating "hand eczema" – Delgocitinib cream]]>news-305<![CDATA[AI-Driven Design of Chelators for Nuclear Drug Development: Challenges]]>news-304<![CDATA[Recommendation for the Development and Synthesis Route of Brexpiprazole]]>news-303<![CDATA[The miracle drug for influenza A – Baloxavir marboxil]]>news-302<![CDATA[Antiviral drug: Amenamevir]]>news-301<![CDATA[Vibegron: Project Proposal and Synthesis Route]]>news-243<![CDATA[Overview and Preparation of Icatibant acetate]]>news-242<![CDATA[In-depth article: N-methylation, α -methylation, D-amino acids, unnatural amino acids for polypeptide]]>news-241<![CDATA[Why Is Pralatrexate Important in Modern Cancer Treatment?]]>news-221<![CDATA[How is MAAA-1162a synthesized?]]>news-163<![CDATA[The synthesis of doxercalciferol]]>news-162<![CDATA[With GLP-1 Regulatory Bars Set at a 0.1% Identification Threshold, Is Your Sucrose Octasulfate-Aluminum Complex (Orforglipron Impurity 18) Reference Standard Robust Enough for Forced Degradation and ANDA Filing?]]>news-161<![CDATA[How Does Migalastat Transform Fabry Disease Treatment?]]>news-122<![CDATA[Biocatalytic cascades enable the manufacturing of the macrocyclic peptide Enlicitide]]>news-121<![CDATA[What Makes Osimertinib a Breakthrough Therapy for Modern Lung Cancer Treatment?]]>news-6<![CDATA[What Makes Sapropterin Important for Managing PKU?]]>news-5<![CDATA[What is pralatrexate?]]>news-4<![CDATA[What is Zanubrutinib?]]>news-3<![CDATA[What are the effects and efficacy of carfilzomib?]]>news-2<![CDATA[What is utpatinib?]]>news-1